Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2026-02-04 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2026-02-04 English
News release - English.pdf
Regulatory Filings
2026-02-04 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings
2026-02-04 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a press release announcing the date and time of Aurora Cannabis’s third quarter 2026 investor conference call and the timing of its financial results release. It does not contain any financial results itself (so it is not an Earnings Release), nor is it the transcript of a call or an investor presentation. It is a general announcement with forward‐looking statements and a webcast link, fitting best as a miscellaneous regulatory announcement. Therefore, it falls under the fallback category “Regulatory Filings” (RNS).
2026-01-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release issued by Aurora Cannabis Inc. regarding scientific research progress in powdery mildew-resistant cultivars. It does not contain financial statements, audit results, or regulatory filings, but rather serves as a corporate update on R&D and operational innovation. Since it does not fit into specific categories like earnings releases (ER) or management reports (MDA), and is a general corporate announcement, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate news.
2026-01-14 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a 'Form 52-109F2', which is a standard Canadian regulatory form for the 'Certification of Interim Filings'. According to the provided Certification Rule, documents that are primarily officer certifications or attestations, even if they reference a specific report type (like interim filings), must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2025
2025-11-05 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.